Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples